Primary urethral cancer: treatment patterns and associated outcomes
- 3 June 2020
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 126 (3), 359-366
- https://doi.org/10.1111/bju.15095
Abstract
Objectives To evaluate treatment patterns and associated outcomes of patients with urethral cancer. Patients and Methods After obtaining institutional review board approval we identified 165 patients treated for primary urethral cancer between 1956 and 2017. Treatment included monotherapy (surgery or radiation), dual therapy (surgery+radiation, surgery+chemotherapy, or chemotherapy+radiation) or triple therapy (surgery+radiation+chemotherapy). Rates of different treatments were described by treatment year. The association between treatment type and outcomes was evaluated with multivariable Cox regression models, adjusting for disease characteristics. Results The study cohort included 74 men and 91 women, with a median age of 61 years. Common histologies were squamous cell (36%), urothelial (27%) and adenocarcinoma (25%). At presentation, 72% of patients had invasive disease, 24% had nodal involvement, and 5% had metastases. Treatment included monotherapy (57%), dual therapy (21%), and triple therapy (10%). The use of monotherapy decreased over time, while rates of dual therapy remained consistent, and rates of triple therapy increased. The median follow-up was 4.7 years. Estimated 5-year local recurrence-free, disease-specific and overall survival were 51%, 48% and 41%, respectively. Monotherapy was associated with decreased local recurrence-free survival after adjusting for stage, histology, sex and year of treatment (P = 0.017). There was no evidence that treatment type was associated with distant recurrence, cancer-specific or overall survival. Conclusions We found preliminary evidence that multimodal therapy, more commonly used in recent years, was of benefit in patients with primary urethral cancer. This finding should be confirmed in further studies involving multiple centres because of the low incidence of the disease.Funding Information
- Sidney Kimmel Foundation for Cancer Research
- National Cancer Institute (P30 CA008748)
This publication has 18 references indexed in Scilit:
- Carcinoma of the urethraHuman Pathology, 2018
- Primary urethral carcinoma: A Surveillance, Epidemiology, and End Results data analysis identifying predictors of cancer-specific survivalUrology Annals, 2018
- Sex-related differences in clinicopathological features and survival of patients with primary urethral carcinoma: a population-based studyOncoTargets and Therapy, 2017
- Outcomes and Prognostic Factors of Primary Urethral CancerUrology, 2017
- Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaWorld Journal of Urology, 2015
- Rare cancers are not so rare: The rare cancer burden in EuropeEuropean Journal of Cancer, 2011
- Incidence and survival of rare urogenital cancers in EuropeEuropean Journal of Cancer, 2011
- Surgical treatment for local control of female urethral carcinomaUrologic Oncology, 2004
- Male urethral carcinoma: analysis of treatment outcomeUrology, 1999
- Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategyBJU International, 1998